The BRCA1 Ashkenazi founder mutations occur on common haplotypes and are not highly correlated with anonymous single nucleotide polymorphisms likely to be used in genome-wide case-control association studies

Authors

Lutecia H. Mateus Pereira, Laboratory of Population Genetics, National Cancer Institute
Marbin A. Pineda, Laboratory of Population Genetics, National Cancer Institute
William H. Rowe, Laboratory of Population Genetics, National Cancer Institute
Liabia R. Fonseca, Department of Biological Sciences, Florida International University
Mark H. Greene, Clinical Genetics Branch, National Cancer Institute
Kenneth Offit, Memorial Sloan Kettering Cancer Center
Nathan A. Ellis, University of Chicago
Jinghui Zhang, Laboratory of Population Genetics, National Cancer Institute
Andrew Collins, Southampton General Hospital
Jeffery P. Struewing, Laboratory of Population Genetics, National Cancer Institute

Date of this Version

10-4-2007

Document Type

Article

Comments

© 2007 Pereira et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Recommended Citation

Mateus Pereira, Lutecia H.; Pineda, Marbin A.; Rowe, William H.; Fonseca, Liabia R.; Greene, Mark H.; Offit, Kenneth; Ellis, Nathan A.; Zhang, Jinghui; Collins, Andrew; and Struewing, Jeffery P., "The BRCA1 Ashkenazi founder mutations occur on common haplotypes and are not highly correlated with anonymous single nucleotide polymorphisms likely to be used in genome-wide case-control association studies" (2007). Department of Biological Sciences. 162.
https://digitalcommons.fiu.edu/cas_bio/162